PASARR screenings not resubmitted for residents with new mental illness diagnoses
Summary
The facility failed to ensure PASARR Level 1 screenings were completed and resubmitted for two residents with mental illness diagnoses and psychotropic medication use. For Resident 10, the record showed diagnoses of paranoid schizophrenia, major depressive disorder, and COPD. The H&P stated the resident could make needs known but could not make medical decisions, and the MDS showed severely impaired cognitive skills for daily decision making. The order summary showed Quetiapine Fumarate and Mirtazapine were started for psychotic disorder with agitation and verbal aggression, and for major depressive disorder. During interview and record review, the DON reviewed Resident 10’s PASARR Level 1 screening and stated it had been completed when the resident had no serious mental illness diagnoses. The DON stated the resident later developed paranoid schizophrenia and that the facility should have completed and resubmitted a new PASARR Level 1 screening under Resident Review because of the new mental illness diagnosis. The DON stated that by not resubmitting the screening, there was a possibility the resident would not be able to avail treatment services for the mental illness diagnosis. For Resident 12, the record showed diagnoses of schizophrenia, major depressive disorder, and psychosis. The MDS indicated the resident was independent in cognitive skills for daily decision making, while the H&P stated the resident had fluctuating capacity to understand and make decisions. The order summary showed Haloperidol was started for schizophrenia manifested by aggressive behavior. The DON reviewed Resident 12’s PASARR Level 1 screening and stated it had been completed when the resident had no serious mental illness diagnoses and was not on psychotropic medications, that the case was closed, and that a PASARR level II mental health evaluation was not required. The DON stated the facility should have completed and resubmitted a new PASARR Level 1 screening under Resident Review because of the resident’s mental illness diagnoses and Haloperidol use, and stated the facility did not follow the PASARR procedure for resubmitting the screening.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.